The Federal Communications Commission, seeking to accelerate the development and deployment of Next Generation 911 (NG911) technology that will enable the public to send emergency communications to 911 Public Safety Answering Points (PSAPs) via text, photos, videos, and data and enhance the information available to PSAPs and first responders for assessing and responding to emergencies, has issued a notice of proposed rulemaking September 26, 2011.
Groundbreaking research has led to the first clinical trial to evaluate the safety of cord blood stem cell treatments for hearing loss. According to a study published in Cell Transplantation, animal subjects treated with cord blood stem cells showed significant healing to the damaged sensory hair cells and neurons in the inner ear. Dr. James Baumgartner, pediatric neurosurgeon, and colleagues at Children’s Memorial Hermann Hospital in Houston will launch the first FDA-regulated clinical trial evaluating the use of cord blood stem cell treatments for children with hearing loss.
A report released by the U.S. Department of Housing and Urban Development (HUD) reveals that discrimination based on a person’s disability continued to be the largest single category of fair housing discrimination complaints filed in fiscal year 2010.
People with hearing loss seem to be among those who love the latest and greatest technology. Early adopters of email, IM, smartphones and text messaging, we are thrilled with world that provides tech solutions for communication problems.
EARtrak is interested in your hearing care experience as a consumer. We would like your opinions about the quality of service, and the performance of your most recently fitted hearing aid/device(s). To obtain your opinion, we would like you to complete the EARtrak survey below. Please be assured that all surveys are confidential, and that your personal information has remained with us unless you choose to have this forwarded to your service provider.